More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Ensign (NASDAQ: ENSG)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the […]
Alignment Healthcare (NASDAQ: ALHC)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment” or the “Company”) for potential violations of the […]
Summit Therapeutics Inc. (NASDAQ: SMMT)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating whether certain officers and directors of Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the […]
News
Lowey Dannenberg Appointed Co-Lead Counsel in Lumen Technologies, Inc. Stockholder Derivative Litigation
On April 21, 2025, Hon. Kayla D. McClusky, United States Magistrate Judge, appointed Lowey Dannenberg, P.C. as the Co-Lead counsel representing Plaintiffs and a proposed class in the consolidated action: In re Lumen Technologies, Inc. Stockholder Derivative...
Blog
SPAC Update
The special purpose acquisition company (“SPAC”) continues to have a profound impact on stock markets. We have written previously about the increasing popularity of SPAC’s and the risks inherent to SPAC’s. The SPAC device attempts to sidestep the SEC review process by bringing companies public...

